Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FENSQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,165
Award facts
- Contract value 100% obligated
- $2,164.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,164.82 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This delivery order, issued on December 26, 2025, falls under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with a $499.999 billion ceiling value established under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to consolidate pharmaceutical supply operations for Department of Defense healthcare facilities worldwide, with DMS Pharmaceutical Group positioned as one of multiple regional prime vendor contractors serving this critical mission.
DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to support military healthcare operations, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical devices. The company's established track record includes delivery of specialized products spanning oncology treatments, immunosuppressants, emergency medications, surgical products, and routine pharmaceuticals. As a critical supplier within the federal pharmaceutical supply chain with no set-aside designation on this particular delivery order, DMS Pharmaceutical Group competes effectively in unrestricted federal procurement while leveraging its small business status, with contract performance extending through December 31, 2036.
Quick answers
Who was awarded contract SPE2DU26FENSQ?
SPE2DU26FENSQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 26, 2025.
How much is contract SPE2DU26FENSQ worth?
The government has obligated $2,165 on SPE2DU26FENSQ.
Is contract SPE2DU26FENSQ an order under another contract?
Yes. SPE2DU26FENSQ is a delivery order under SPE2DU25D9420, an indefinite delivery contract.
Was contract SPE2DU26FENSQ competed?
The extent of competition for SPE2DU26FENSQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award